ESPE Abstracts (2024) 98 P2-53

1Erasmus Medical Center - Sophia Children’s Hospital, Rotterdam, Netherlands. 2Dutch Growth Research Foundation, Rotterdam, Netherlands


Background and Aims: Extreme preterm birth (EPB), <30 weeks gestation, significantly impacts skeletal development due to decreased bone mineralization, with approximately 16-40% of EPBs developing metabolic bone disease of prematurity (MBDP). To investigate if MBDP persists into childhood with the current feeding protocols for EPBs, our objective was to compare bone mineral density (BMD) around (corrected) age 5 years in EPB children versus children born term.

Methods: We included 108 EPB children and 269 healthy term-born children of two observational cohort studies in the Netherlands. We prospectively determined BMD of the total body less head (TBLH) by Dual-energy X-ray Absorptiometry (DXA) around age 5 years. Age- and sex-adjusted Standard Deviation Scores (SDS) were calculated for both cohorts. Student t-test was used to compare BMDTBLH SDS between both cohorts. Multiple linear regression analyses were performed to evaluate which birth, maternal, neonatal, child and growth characteristics are associated with BMDTBLH SDS in both cohorts. Analysis of covariance (ANCOVA) was performed to analyze the difference of BMDTBLH SDS between cohorts, while corrected for significant variables found in the regression analyses.

Results: At around 5 years, EPB children had lower mean (SD) length SDS, weight-for-height SDS, lean body mass (LBM) SDS, fat mass (FM) SDS and a lower BMDTBLH SDS compared to term-born children (-0.41 (1.2) vs. 0.04 (1.1), P <0.001). Length SDS (β=0.57, P <0.001) (β=0.49, P <0.001), weight-for-length SDS (β=0.29, P <0.001) (β=0.43, P <0.001), LBM SDS (β=0.57, P <0.001) (β=0.56, P <0.001) and FM SDS (both cohorts β=0.25, P <0.001) were positively associated with BMDTBLH SDS in EPB children and term-born children, respectively. Non-Caucasian ethnicity was only positively associated in EPB children (β=0.20, P = 0.008). Birth, maternal and neonatal characteristics were not associated with BMDTBLH SDS at around 5 years. The ANCOVA analyses, including length SDS, weight-for-length SDS, LBM SDS and FM SDS as covariates, found no difference in BMDTBLH SDS between EPB children and term-born children (-0.07 (95% confidence interval (CI) -0.23 – 0.09) vs. -0.09 (95% CI -0.18 – 0.01), P = 0.85).

Conclusion: EPB children have a lower BMDTBLH SDS around (corrected) age 5 years compared to term-born children. However, BMDTBLH SDS was well in the normal range in both cohorts. Lower BMDTBLH SDS in EPB children seems not to be caused by the bone itself, but explained by anthropometrics and body composition parameters, especially lower length SDS and LBM SDS. Indicating that, under current feeding protocol, MBDP generally does not persist into young childhood.

Volume 98

62nd Annual ESPE (ESPE 2024)

Liverpool, UK
16 Nov 2024 - 18 Nov 2024

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches